Ara
Toplam kayıt 28, listelenen: 11-20
Can NLR, PLR, and LMR be used as prognostic indicators in patients with pulmonary embolism? Author's reply on commentary COMMENT
(ASSOC BASIC MEDICAL SCI FEDERATION BOSNIA & HERZEGOVINA SARA, 2021)
We appreciate the comments made by Dr Bedel and colleagues. NLR, PLR and LMR are affected by various diseases such as oncological, collagen tissue, inflammatory, or severe renal/liver diseases [1]. Because of this, we have ...
Lower Muscle Strength and Increased Visceral Fat Associated With No-reflow and High Gensini Score in STEMI
(Sage Publications Inc, 2017)
Background: The impact of fat distribution, muscle mass, and muscle strength on no-reflow and severity of coronary artery disease in patients with ST-segment elevation myocardial infarction (STEMI) remains unclear. Objective: ...
Platelet indices and stroke
(Taylor & Francis Ltd, 2018)
Right Ventricular Functions in Pulmonary Thromboembolism
(Karger, 2018)
An unusual cause of dyspnea: Spontaneous pneumopericardium
(Turkish Soc Cardiology, 2018)
Predictors of poor coronary collateral development in patients with stable coronary artery disease: Neutrophil-to-lymphocyte ratio and platelets
(Turkish Soc Cardiology, 2015)
Objective: The heterogeneity in the degree of collateralization among patients with coronary artery disease (CAD) remains incompletely understood. We evaluated the predictors of poorly developed coronary collateral circulation ...
Increased Transforming Growth Factor- Levels Associated With Cardiac Adverse Events in Hypertrophic Cardiomyopathy
(Wiley, 2015)
BackgroundHypertrophic cardiomyopathy (HCM) is a common genetic heart disease characterized by ventricular hypertrophy, myocardial fibrosis, and impaired ventricular relaxation. The exact mechanisms by which fibrosis is ...